American Portfolios Advisors’s Epizyme, Inc EPZM Stock Holding History

American Portfolios Advisors’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-200	Closed	-$294	–	3634
2022 Q2	$294	Hold	200	–	–	﹤0.01%	3436
2022 Q1	$230	Hold	200	–	–	﹤0.01%	3525
2021 Q4	$500	Hold	200	–	–	﹤0.01%	3412
2021 Q3	$1.02K	Hold	200	–	–	﹤0.01%	3298
2021 Q2	$1.66K	Hold	200	–	–	﹤0.01%	3178
2021 Q1	$1.74K	Hold	200	–	–	﹤0.01%	3024
2020 Q4	$2.17K	Hold	200	–	–	﹤0.01%	2681
2020 Q3	$2.39K	Hold	200	–	–	﹤0.01%	2541
2020 Q2	$3.21K	Hold	200	–	–	﹤0.01%	2384
2020 Q1	$3.1K	Buy	+200	New	+$4.29K	﹤0.01%	2256

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

American Portfolios Advisors's EPZM Position: Q3 2022 in Review

American Portfolios Advisors sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 200 shares — an estimated $294 sold.

American Portfolios Advisors first reported a position in EPZM in Q1 2020 and held it in 10 quarters. The position peaked at $3.21K in Q2 2020. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

American Portfolios Advisors reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
American Portfolios Advisors sold 200 Epizyme, Inc shares in Q3 2022, an estimated $294.
American Portfolios Advisors first reported a position in Epizyme, Inc in Q1 2020 and held it in 10 quarters.
American Portfolios Advisors's Epizyme, Inc position peaked at $3.21K in Q2 2020.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.